Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Corboy
Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two-Year Experience
Multiple Sclerosis Journal – Experimental, Translational and Clinical
Related publications
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
HDL-cholesterol Elevation Associated With Fingolimod and Dimethyl Fumarate Therapies in Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Dimethyl Fumarate Treatment Alters NK Cell Function in Multiple Sclerosis
European Journal of Immunology
Allergy
Immunology
Dimethyl Fumarate for Relapsingremitting Multiple Sclerosis
Prescriber
Pharmacology
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases
Frontiers in Immunology
Allergy
Immunology
Dimethyl Fumarate in the Management of Multiple Sclerosis: Appropriate Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment
Neurology
Neurology
Debate on the Treatment of Multiple Sclerosis: Experience From an Intractable Multiple Sclerosis Case With Rebound Syndrome After Fingolimod Cessation
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Nonfatal PML in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate
Neurology: Neuroimmunology and NeuroInflammation
Neurology
